|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.98 EUR | +0.62% |
|
-2.28% | +8.94% |
| 05-18 | Symbio continues transformation backed by co-shareholders Michelin and Forvia | |
| 05-08 | MICHELIN : JP Morgan reaffirms its Neutral rating | ZD |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.37 | 6.01 | 5.91 | 5.34 | 4.36 | |||||
Return on Total Capital | 8.03 | 8.83 | 8.56 | 7.71 | 6.22 | |||||
Return On Equity % | 13.37 | 12.52 | 11.31 | 10.33 | 9.07 | |||||
Return on Common Equity | 13.32 | 12.46 | 11.29 | 10.28 | 9.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.35 | 26.37 | 28.04 | 28.49 | 27 | |||||
SG&A Margin | 13.91 | 12.11 | 12.84 | 13.17 | 13.62 | |||||
EBITDA Margin % | 18.6 | 17.71 | 17.99 | 18.14 | 16.61 | |||||
EBITA Margin % | 13.1 | 12.75 | 12.85 | 12.56 | 10.92 | |||||
EBIT Margin % | 11.98 | 11.75 | 11.78 | 11.4 | 9.72 | |||||
Income From Continuing Operations Margin % | 7.75 | 7.03 | 7 | 6.95 | 6.4 | |||||
Net Income Margin % | 7.75 | 7 | 7 | 6.93 | 6.41 | |||||
Net Avail. For Common Margin % | 7.73 | 6.99 | 6.99 | 6.92 | 6.39 | |||||
Normalized Net Income Margin | 6.79 | 6.62 | 7.21 | 6.88 | 6.05 | |||||
Levered Free Cash Flow Margin | 5.9 | -1.44 | 10.49 | 6.36 | 8.19 | |||||
Unlevered Free Cash Flow Margin | 6.44 | -0.77 | 11.14 | 6.85 | 8.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.72 | 0.82 | 0.8 | 0.75 | 0.72 | |||||
Fixed Assets Turnover | 1.97 | 2.25 | 2.14 | 1.99 | 1.91 | |||||
Receivables Turnover (Average Receivables) | 6.96 | 7.35 | 7.04 | 7.31 | 7.05 | |||||
Inventory Turnover (Average Inventory) | 3.64 | 3.68 | 3.47 | 3.49 | 3.52 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.67 | 1.67 | 1.77 | 1.76 | 1.9 | |||||
Quick Ratio | 0.99 | 0.84 | 0.93 | 0.96 | 1.1 | |||||
Operating Cash Flow to Current Liabilities | 0.32 | 0.21 | 0.68 | 0.5 | 0.51 | |||||
Days Sales Outstanding (Average Receivables) | 52.41 | 49.67 | 51.87 | 50.1 | 51.8 | |||||
Days Outstanding Inventory (Average Inventory) | 100.22 | 99.11 | 105.28 | 104.9 | 103.81 | |||||
Average Days Payable Outstanding | 65.61 | 63.95 | 71.19 | 68.57 | 70.77 | |||||
Cash Conversion Cycle (Average Days) | 87.03 | 84.83 | 85.95 | 86.43 | 84.84 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 53.45 | 43.55 | 34.76 | 39.92 | 36.76 | |||||
Total Debt / Total Capital | 34.83 | 30.34 | 25.79 | 28.53 | 26.88 | |||||
LT Debt/Equity | 40.69 | 31.52 | 30.13 | 31.16 | 31.95 | |||||
Long-Term Debt / Total Capital | 26.51 | 21.96 | 22.36 | 22.27 | 23.36 | |||||
Total Liabilities / Total Assets | 56.86 | 51.58 | 48.98 | 50.11 | 48.38 | |||||
EBIT / Interest Expense | 13.97 | 11.02 | 11.28 | 14.76 | 9.91 | |||||
EBITDA / Interest Expense | 22.85 | 17.39 | 18.06 | 24.69 | 17.89 | |||||
(EBITDA - Capex) / Interest Expense | 15.53 | 11.1 | 11.29 | 15.62 | 11.17 | |||||
Total Debt / EBITDA | 1.72 | 1.41 | 1.17 | 1.43 | 1.46 | |||||
Net Debt / EBITDA | 0.66 | 0.86 | 0.64 | 0.62 | 0.54 | |||||
Total Debt / (EBITDA - Capex) | 2.53 | 2.2 | 1.87 | 2.27 | 2.33 | |||||
Net Debt / (EBITDA - Capex) | 0.97 | 1.35 | 1.03 | 0.98 | 0.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 16.25 | 20.15 | -0.86 | -4.06 | -4.42 | |||||
Gross Profit, 1 Yr. Growth % | 22.22 | 7.92 | 5.44 | -2.52 | -9.41 | |||||
EBITDA, 1 Yr. Growth % | 30.28 | 11.84 | 3.18 | -3.26 | -12.47 | |||||
EBITA, 1 Yr. Growth % | 51.95 | 13.26 | 3.38 | -6.23 | -16.87 | |||||
EBIT, 1 Yr. Growth % | 59.49 | 13.86 | 3.12 | -7.16 | -18.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 195.2 | 8.89 | -1.29 | -4.69 | -11.96 | |||||
Net Income, 1 Yr. Growth % | 191.77 | 8.51 | -0.9 | -4.99 | -11.62 | |||||
Normalized Net Income, 1 Yr. Growth % | 80.63 | 12.77 | 12.6 | -8.52 | -15.84 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 191.74 | 8.98 | -1.43 | -4.73 | -11.07 | |||||
Accounts Receivable, 1 Yr. Growth % | 19.25 | 17.59 | -8.44 | -6.62 | -4.92 | |||||
Inventory, 1 Yr. Growth % | 33.16 | 23.52 | -13.79 | 4.63 | -10.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.03 | 7.18 | 1.49 | 4.8 | -5.51 | |||||
Total Assets, 1 Yr. Growth % | 9.68 | 2.32 | -0.43 | 6.13 | -6.25 | |||||
Tangible Book Value, 1 Yr. Growth % | 27.71 | 18.39 | 2.35 | 3.77 | -1.5 | |||||
Common Equity, 1 Yr. Growth % | 18.53 | 14.26 | 4.94 | 3.73 | -2.97 | |||||
Cash From Operations, 1 Yr. Growth % | -13.67 | -33.55 | 173.8 | -17.99 | -11.92 | |||||
Capital Expenditures, 1 Yr. Growth % | 25.02 | 28.45 | 4.43 | -4.99 | -9.98 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -40.24 | -128.06 | -710.01 | -41.81 | 22.98 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -38.58 | -113.86 | -1.16K | -41.03 | 22.87 | |||||
Dividend Per Share, 1 Yr. Growth % | 95.65 | 11.11 | 8 | 2.22 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.71 | 18.18 | 9.14 | -2.47 | -4.24 | |||||
Gross Profit, 2 Yr. CAGR % | -0.69 | 14.85 | 6.67 | 1.38 | -6.03 | |||||
EBITDA, 2 Yr. CAGR % | -0.78 | 22.08 | 6.11 | -0.09 | -7.98 | |||||
EBITA, 2 Yr. CAGR % | -0.26 | 33.3 | 6.37 | -1.54 | -11.71 | |||||
EBIT, 2 Yr. CAGR % | -0.49 | 37.12 | 6.36 | -2.15 | -13.01 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.27 | 79.29 | 3.67 | -3.01 | -8.4 | |||||
Net Income, 2 Yr. CAGR % | 2.62 | 77.94 | 3.7 | -2.97 | -8.37 | |||||
Normalized Net Income, 2 Yr. CAGR % | 0.56 | 45.49 | 10.37 | 1.49 | -12.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.96 | 78.31 | 3.64 | -3.09 | -7.95 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.59 | 16.15 | 3.76 | -7.54 | -3.36 | |||||
Inventory, 2 Yr. CAGR % | 5.98 | 26.33 | 3.19 | -5.02 | -3.3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.49 | 5.09 | 4.3 | 3.13 | -0.49 | |||||
Total Assets, 2 Yr. CAGR % | 4.66 | 5.7 | 0.94 | 2.8 | -0.25 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12.74 | 22.96 | 10.07 | 3.06 | 1.1 | |||||
Common Equity, 2 Yr. CAGR % | 6.4 | 16.38 | 9.5 | 4.33 | 0.33 | |||||
Cash From Operations, 2 Yr. CAGR % | -6.46 | -24.26 | 34.88 | 49.85 | -15.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.19 | 26.72 | 15.82 | -0.39 | -7.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -8.74 | -58.14 | 42.35 | 88.46 | -15.41 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -9.55 | -70.23 | 40.72 | 150.01 | -14.88 | |||||
Dividend Per Share, 2 Yr. CAGR % | 50 | 47.44 | 9.54 | 5.07 | 1.1 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.61 | 5.81 | 11.46 | 4.55 | -3.13 | |||||
Gross Profit, 3 Yr. CAGR % | 2.37 | 2.1 | 11.62 | 3.52 | -2.35 | |||||
EBITDA, 3 Yr. CAGR % | 3.38 | 4.04 | 14.48 | 2.89 | -4.4 | |||||
EBITA, 3 Yr. CAGR % | 3.66 | 5.17 | 21.07 | 1.99 | -6.94 | |||||
EBIT, 3 Yr. CAGR % | 2.79 | 5.3 | 23.16 | 1.64 | -7.93 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.58 | 5.11 | 46.94 | 0.81 | -6.09 | |||||
Net Income, 3 Yr. CAGR % | 3.21 | 4.55 | 46.4 | 0.72 | -5.94 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.55 | 5.82 | 31.74 | 3.68 | -4.65 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.45 | 4.93 | 46.34 | 0.78 | -5.83 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.49 | 5.99 | 7.29 | 0.18 | -5.08 | |||||
Inventory, 3 Yr. CAGR % | 3.89 | 10.41 | 11.22 | 3.67 | -6.93 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.75 | -0.06 | 3.87 | 4.46 | 0.17 | |||||
Total Assets, 3 Yr. CAGR % | 4.83 | 3.72 | 3.62 | 2.64 | -0.31 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.81 | 14.59 | 15.66 | 7.93 | 1.51 | |||||
Common Equity, 3 Yr. CAGR % | 7.19 | 8.96 | 12.43 | 7.54 | 1.84 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.88 | -16.54 | 16.24 | 14.27 | 25.52 | |||||
Capital Expenditures, 3 Yr. CAGR % | -0.9 | 6.38 | 18.81 | 8.42 | -3.7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.4 | -37.49 | 8.16 | 5.67 | 63.47 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 9.54 | -50.94 | 8.19 | 5.31 | 97.3 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.74 | 35.72 | 32.91 | 7.05 | 3.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.62 | 5.42 | 5.17 | 2.41 | 4.89 | |||||
Gross Profit, 5 Yr. CAGR % | -0.32 | 1.08 | 4.07 | 1.81 | 4.2 | |||||
EBITDA, 5 Yr. CAGR % | 2.33 | 4.92 | 4.93 | 1.86 | 4.9 | |||||
EBITA, 5 Yr. CAGR % | 2.94 | 5.49 | 5.41 | 1.73 | 6.71 | |||||
EBIT, 5 Yr. CAGR % | 2.23 | 4.97 | 4.93 | 1.49 | 7.17 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.05 | 3.48 | 3.62 | 1.78 | 21.63 | |||||
Net Income, 5 Yr. CAGR % | 1.93 | 3.31 | 3.41 | 1.48 | 21.38 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.66 | 4.02 | 6.42 | 3.21 | 11.97 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.55 | 3.62 | 3.53 | 1.64 | 21.57 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.09 | 6.4 | 2.2 | 0.35 | 2.9 | |||||
Inventory, 5 Yr. CAGR % | 3.31 | 6.98 | 2.99 | 3.96 | 5.17 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.1 | 3.85 | 2.76 | 1.21 | 2.11 | |||||
Total Assets, 5 Yr. CAGR % | 6.5 | 6.94 | 3.16 | 3.35 | 2.05 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.85 | 6.61 | 11.11 | 9.83 | 9.6 | |||||
Common Equity, 5 Yr. CAGR % | 7.16 | 8.79 | 8.11 | 7.09 | 7.42 | |||||
Cash From Operations, 5 Yr. CAGR % | 1 | -6.77 | 13.31 | 5.48 | 2.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.82 | 2.84 | 5.48 | 3.62 | 7.48 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.96 | -23.37 | 23.3 | 0.53 | -1.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.84 | -33.17 | 22.07 | -0.11 | -1.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.72 | 7.09 | 7.85 | 22.51 | 19.14 |
- Stock Market
- Equities
- ML Stock
- Financials Michelin (CGDE)
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















